Deluxe Corporation
NYSE:DLXAdvertising Agencies
-$0.37 today
- Market cap
- $1.23B
- Beta
- 1.22
- P/E (TTM)
- 10.3
- EPS (TTM)
- $2.24
- Dividend yield
- 5.20%
Volume 0.57M
Average 0.44M
DLX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Deluxe CorporationNYSE: DLX
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How DLX compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for DLX, versus a peer median of 2.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CN¥1.06B CNY | -15.4% | -10.0% | 17.6% | |
| LTM Mar 2026 | $98.97M USD | +13.5% | +10.8% | 10.5% | |
| LTM Mar 2026 | $85.1M USD | -5.7% | -0.7% | 19.8% | |
| LTM Mar 2026 | $34.39M USD | +1.8% | +15.6% | 2.9% | |
| LTM Mar 2026 | $32.57M USD | +7.9% | -0.2% | 4.5% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding DLX) | — | +1.8% | -0.2% | 2.9% | |
Competitors are the stored peer set for DLX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.02B | 2.24B | 2.19B | 2.12B | 2.13B |
| Cost of Revenue | 884.27M | 1.03B | 1.03B | 995.31M | 1B |
| Gross Profit | 1.14B | 1.21B | 1.16B | 1.13B | 1.13B |
| Gross Margin | 56.3% | 53.9% | 53.0% | 53.1% | 53.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 941.02M | 993.25M | 956.07M | 909.17M | 873.3M |
| Operating Expenses | 995.77M | 1.04B | 1B | 934.27M | 873.3M |
| Depreciation & Amortization | 148.77M | 172.55M | 169.7M | 165.54M | 137.9M |
| EBITDA | 298.12M | 351.38M | 335.15M | 365.32M | 379M |
| EBITDA Margin | 14.7% | 15.7% | 15.3% | 17.2% | 17.8% |
| Operating Income | 142.15M | 169.45M | 160.79M | 192.18M | 258.6M |
| Operating Margin | 7.0% | 7.6% | 7.3% | 9.1% | 12.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 55.55M | 94.45M | 125.64M | 123.28M | 122M |
| Other Income / Expenses | (48.35M) | (85.07M) | (120.99M) | (115.68M) | (139.5M) |
| Income Before Tax | 93.8M | 84.38M | 39.8M | 76.5M | 119.1M |
| Pre-Tax Margin | 4.6% | 3.8% | 1.8% | 3.6% | 5.6% |
| Income Tax Expense | 31.03M | 18.85M | 13.57M | 23.55M | 36.9M |
| Net Income | 62.63M | 65.4M | 26.12M | 52.8M | 82.1M |
| Net Margin | 3.1% | 2.9% | 1.2% | 2.5% | 3.8% |
| EPS (Basic) | 1.48 | 1.52 | 0.60 | 1.20 | 1.87 |
| EPS (Diluted) | 1.45 | 1.50 | 0.59 | 1.18 | 1.80 |
| Weighted Avg Shares | 42.38M | 43.03M | 43.55M | 44.15M | 45.5M |
| Weighted Avg Shares (Diluted) | 42.83M | 43.31M | 43.84M | 44.73M | 45.5M |
Deluxe Corporation
NYSE:DLX
Intrinsic Alpha fair value
Locked
Current Price
$26.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.